Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current Assets:    
Cash (Note 2) $ 2,302,418us-gaap_CashAndCashEquivalentsAtCarryingValue $ 2,243,670us-gaap_CashAndCashEquivalentsAtCarryingValue
Accounts Receivable, net (Note 2) 282,407us-gaap_AccountsReceivableNetCurrent 1,430,202us-gaap_AccountsReceivableNetCurrent
Notes receivable - current portion (Note 3) 1,508,468us-gaap_NotesAndLoansReceivableNetCurrent 0us-gaap_NotesAndLoansReceivableNetCurrent
Prepaid Inventory 519,620us-gaap_OtherPrepaidExpenseCurrent 1,734,831us-gaap_OtherPrepaidExpenseCurrent
Inventory (Note 4) 11,666,251us-gaap_InventoryNet 2,473,322us-gaap_InventoryNet
Prepaid expenses and other current assets 527,104us-gaap_PrepaidExpenseCurrent 174,317us-gaap_PrepaidExpenseCurrent
Total Current Assets 16,806,268us-gaap_AssetsCurrent 8,056,342us-gaap_AssetsCurrent
Property & equipment, net (Note 2) 516,423us-gaap_PropertyPlantAndEquipmentNet 214,128us-gaap_PropertyPlantAndEquipmentNet
Intangibles, net (Note 6) 2,535,000us-gaap_FiniteLivedIntangibleAssetsNet 3,356,500us-gaap_FiniteLivedIntangibleAssetsNet
Goodwill (Note 6) 1,855,512us-gaap_Goodwill 1,855,512us-gaap_Goodwill
Accounts receivable, net of current portion 0us-gaap_AccountsReceivableNetNoncurrent 310,300us-gaap_AccountsReceivableNetNoncurrent
Note receivable - long term portion (Note 3) 26,705us-gaap_NotesAndLoansReceivableNetNoncurrent 0us-gaap_NotesAndLoansReceivableNetNoncurrent
Investment in KannaLife Sciences (Note 7) 0us-gaap_Investments 439,246us-gaap_Investments
Total Other Assets 4,933,640us-gaap_AssetsNoncurrent 6,175,686us-gaap_AssetsNoncurrent
TOTAL ASSETS 21,739,908us-gaap_Assets 14,232,028us-gaap_Assets
Current Liabilities:    
Accounts payable 546,387us-gaap_AccountsPayableCurrent 24,622us-gaap_AccountsPayableCurrent
Accrued expenses (Note 5) 118,206us-gaap_AccruedLiabilitiesCurrent 222,703us-gaap_AccruedLiabilitiesCurrent
Common stock to be issued (Note 10) 0canv_CommonStockToBeIssued 175,000canv_CommonStockToBeIssued
Amount due to related party 0us-gaap_AccountsPayableRelatedPartiesCurrent 300us-gaap_AccountsPayableRelatedPartiesCurrent
Total current liabilities 664,593us-gaap_LiabilitiesCurrent 422,625us-gaap_LiabilitiesCurrent
Non-current liabilities    
Line of credit - Roen Ventures, LLC, net of debt discount (Note 9) 0us-gaap_DueToOtherRelatedPartiesNoncurrent 5,502,595us-gaap_DueToOtherRelatedPartiesNoncurrent
Total liabilities 664,593us-gaap_Liabilities 5,925,220us-gaap_Liabilities
Commitments and contingencies (Note 12)      
Stockholders' equity (Note 10)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized; no shares issued and outstanding 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, par value $0.0001; 190,000,000 shares authorized; 33,419,166 and 15,580,000 shares issued and outstanding as of December 31, 2014 and 2013, respectively 3,341us-gaap_CommonStockValue 1,558us-gaap_CommonStockValue
Additional paid-in capital 24,828,337us-gaap_AdditionalPaidInCapital 10,749,662us-gaap_AdditionalPaidInCapital
Accumulated Deficit (3,756,363)us-gaap_RetainedEarningsAccumulatedDeficit (2,444,412)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders' equity 21,075,315us-gaap_StockholdersEquity 8,306,808us-gaap_StockholdersEquity
Total liabilities and stockholders' equity $ 21,739,908us-gaap_LiabilitiesAndStockholdersEquity $ 14,232,028us-gaap_LiabilitiesAndStockholdersEquity